HOME >> MEDICINE >> NEWS
SNM and ACNP CMS PET reimbursement statement

CMS new reimbursement rate for FDG PET of $1375.00 has both good and disappointing news for those interested in bringing Positron Emission Tomography (PET) to the broadest number of patients, according to the Society of Nuclear Medicine (SNM) and the American College of Nuclear Physicians (ACNP).

SNM and ACNP believe that this lower rate (down from the previous $2,331.18) may have a negative impact on the expansion of PET services into communities where it does not currently exist, since it will be more difficult for hospitals and other facilities to recoup the significant costs associated with the installation and operation of PET centers. This is unfortunate, since PET is increasingly used in clinical medicine, and is a vital diagnostic and treatment planning tool for many cancers, neurological and cardiac conditions.

On the positive side, SNM and ACNP are pleased at CMSs responsiveness to the concerns expressed when proposed reduced reimbursement amounts were first posted in August. This was particularly significant as it relates to the cost of the 18-flurodeoxyglocose (FDG) injected as part of the PET scan process. CMS originally proposed an FDG PET reimbursement of $841.50, when the published average wholesale price (AWP) for FDG is $750. Facilities would lose money with each scan.

This process demonstrated that the medical profession and the government can work together, stated Alan Maurer, M.D., President of the SNM. We were able to show how there were errors in the data on which CMS had originally based its proposed reimbursement, and the agency responded by developing a more reasonable, though still disappointing, reimbursement amount.

Because CMS relies on data to make its reimbursement decisions, this effort also demonstrates how important it is for those of us in the PET field to be particularly precise when we code and submit claims to the agency. We look forward to working with CMS in the future on this, and to e
'"/>

Contact: William Uffelman
wuffelman@snm.org
703-708-9000
Society of Nuclear Medicine
30-Nov-2001


Page: 1 2

Related medicine news :

1. Study finds Medicare overbilling may be caused by governments faulty reimbursement
2. NHLBI statement on oral contraceptive study
3. NIH panel issues State-of-the-Science statement on end-of-life care
4. Doctors statement in Mayo Clinic Proceedings reveals dark side of low-carb diets
5. American Heart Association consensus statement
6. NIA statement on IOM testosterone report
7. American Psychiatric Association issues statement on compulsive shopping
8. New statement proposes ways to stop deadly drug errors among heart, stroke patients
9. Aventis Pasteur statement on HVTN 501 decision

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: SNM and ACNP CMS PET reimbursement statement

(Date:4/18/2015)... Carinsurancehints.com has released a new blog post ... offer financial protection against fire damage. , Clients can ... case their vehicle is set intentionally on fire. This type ... or by other things. , It is possible to ... website http://www.carinsurancehints.com/ , in just a few minutes. ...
(Date:4/18/2015)... "I wanted to live a ... healthful juice that contained essential vitamins, minerals and ... increases my energy, improves skin elasticity and gives ... Tapp's Juice to contain fruits, vegetables and other ... and mental fatigue. It features a great taste. ...
(Date:4/18/2015)... April 18, 2015 Insuranceautoquote.info has released ... online auto insurance quotes . , Clients can ... single website. The online environment provides important advantages for ... , Drivers who do not have coverage for ... during any season, day or hour. Many agencies offer ...
(Date:4/18/2015)... 18, 2015 Lower-auto-insurance.com has released a ... auto insurance quotes . , Drivers can ... comparing quotes. A professional insurance brokerage website can help ... in a simple, convenient way. The whole process is ... , Comparing online car insurance quotes is advantageous ...
(Date:4/18/2015)... 2015 Thousand of DePuy Pinnacle hip ... individuals who were allegedly harmed by a metal-on-metal version ... in the U.S. District Court, Northern District of Texas. ... has amended an earlier Case Management Order to allow ... the new amendment permits the claims of up to ...
Breaking Medicine News(10 mins):Health News:Online Auto Insurance Quotes For Plans That Cover Fire Damages! 2Health News:Clients Can Review Car Insurance Quotes Online To Find Low Cost Offers! 2Health News:Auto Insurance Quotes Can Provide Accurate Results! 2Health News:DePuy Pinnacle Hip Lawsuits: Federal Litigation Amends Case Management Order to Allow for Joinder of Unrelated Claims 2Health News:DePuy Pinnacle Hip Lawsuits: Federal Litigation Amends Case Management Order to Allow for Joinder of Unrelated Claims 3
(Date:4/17/2015)... DALLAS , April 17, 2015 ... report 2015 Market Research Report on Global and ... This is a professional and the deep ... the report introduces Lysine basic information including definition, ... overview (such as US, Europe ...
(Date:4/17/2015)... 2015 CVS Health Corporation (NYSE: CVS ... May 1, 2015, at 8:30 a.m. (EDT) with analysts ... An audio webcast of the conference call ... of the CVS Health website for all interested parties. ... webcast will be archived and available on the web ...
(Date:4/17/2015)... , April 17, 2015  Trovagene, Inc., ... announced today that clinical data presented at the ... its urine-based Precision Cancer Monitoring ℠ (PCM) ... monitoring of EGFR T790M mutations in ... Detection of EGFR T790M Mutation in Urinary Circulating ...
Breaking Medicine Technology:Lysine Market International (US, Europe, Japan) Research Analysis 2Lysine Market International (US, Europe, Japan) Research Analysis 3Lysine Market International (US, Europe, Japan) Research Analysis 4Lysine Market International (US, Europe, Japan) Research Analysis 5Trovagene's Urinary ctDNA Assay Outperforms Tissue Biopsy in Clinical Study for the Detection of EGFR T790M Mutations in Metastatic Lung Cancer Patients 2Trovagene's Urinary ctDNA Assay Outperforms Tissue Biopsy in Clinical Study for the Detection of EGFR T790M Mutations in Metastatic Lung Cancer Patients 3Trovagene's Urinary ctDNA Assay Outperforms Tissue Biopsy in Clinical Study for the Detection of EGFR T790M Mutations in Metastatic Lung Cancer Patients 4
Cached News: